Your browser doesn't support javascript.
loading
Primary Immunodeficiency Diseases in Aguascalientes, Mexico: Results from an Educational Program.
Alvarez-Cardona, Aristoteles; Espinosa-Padilla, Sara Elva; Reyes, Saul Oswaldo Lugo; Ventura-Juarez, Javier; Lopez-Valdez, Jaime Asael; Martínez-Medina, Lucila; Santillan-Artolozaga, Alberto; Cajero-Avelar, Adriana; De Luna-Sosa, Alma R; Torres-Bernal, Luis F; Espinosa-Rosales, Francisco J.
Afiliação
  • Alvarez-Cardona A; Universidad Autonoma de Aguascalientes, Aguascalientes, Mexico.
  • Espinosa-Padilla SE; Immunodeficiencies Research Unit, a Jeffrey Modell Diagnostic Center at the National Institute of Pediatrics, Mexico City, Mexico.
  • Reyes SO; Immunodeficiencies Research Unit, a Jeffrey Modell Diagnostic Center at the National Institute of Pediatrics, Mexico City, Mexico.
  • Ventura-Juarez J; Universidad Autonoma de Aguascalientes, Aguascalientes, Mexico.
  • Lopez-Valdez JA; Centennial Hospital Miguel Hidalgo, Aguascalientes, Mexico.
  • Martínez-Medina L; Centennial Hospital Miguel Hidalgo, Aguascalientes, Mexico.
  • Santillan-Artolozaga A; Centennial Hospital Miguel Hidalgo, Aguascalientes, Mexico.
  • Cajero-Avelar A; Centennial Hospital Miguel Hidalgo, Aguascalientes, Mexico.
  • De Luna-Sosa AR; Centennial Hospital Miguel Hidalgo, Aguascalientes, Mexico.
  • Torres-Bernal LF; Centennial Hospital Miguel Hidalgo, Aguascalientes, Mexico.
  • Espinosa-Rosales FJ; Immunodeficiencies Research Unit, a Jeffrey Modell Diagnostic Center at the National Institute of Pediatrics, Mexico City, Mexico. espinosa_francisco@yahoo.com.mx.
J Clin Immunol ; 36(3): 173-8, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26898367
ABSTRACT

PURPOSE:

Primary immunodeficiencies (PIDs) are a heterogeneous group of disorders characterized mainly by recurrent infections. Late diagnosis remains as one of the main issues to solve. We aimed to increase PID diagnosis in Aguascalientes, a 1.3 million inhabitants state in the center of Mexico, and to describe the clinical features of such patients.

METHODS:

We developed an educational program for health personnel and general public; patients with possible PID were referred to a State University clinical center from December 2011 to December 2012. The patients were evaluated at the clinic and their definitive diagnosis pursued through laboratory, molecular and genetic assays. We describe the findings of those patients and analyze the impact of the program in terms of number of referrals.

RESULTS:

After 41 talks and 12 media appearances 151 patients were referred for evaluation. Fifteen (9.9%) were diagnosed with PID five (33%) had antibody deficiencies, seven (47%) Well-defined syndromes, two (13%) Severe combined Immunodeficiency (SCID) and one case (7%) of an innate immune deficiency. All of the 15 PID patients had been referred by physicians, as opposed to the public. We estimated a "number needed to teach" of 75 physicians to get one PID patient referral.

CONCLUSION:

Educational programs are a fundamental part of the global efforts to increase PID diagnosis and care. To be successful, such programs should include public relations, reach for first-contact physicians, and aim to develop an efficient referral network with molecular diagnostic capability. Enhancing medical knowledge on PID is a successful strategy to improve early diagnosis and treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema de Registros / Conhecimentos, Atitudes e Prática em Saúde / Síndromes de Imunodeficiência Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema de Registros / Conhecimentos, Atitudes e Prática em Saúde / Síndromes de Imunodeficiência Idioma: En Ano de publicação: 2016 Tipo de documento: Article